• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经精神疾病和认知功能障碍中的 microRNA 失调。

MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

机构信息

Department of Physiology & Cellular Biophysics, Columbia University, New York, NY, USA.

出版信息

Neurobiol Dis. 2012 May;46(2):291-301. doi: 10.1016/j.nbd.2012.02.016. Epub 2012 Mar 3.

DOI:10.1016/j.nbd.2012.02.016
PMID:22406400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3329786/
Abstract

MicroRNAs (miRNA), a class of non-coding RNAs, are emerging as important modulators of neuronal development, structure and function. A connection has been established between abnormalities in miRNA expression and miRNA-mediated gene regulation and psychiatric and neurodevelopmental disorders as well as cognitive dysfunction. Establishment of this connection has been driven by progress in elucidating the genetic etiology of these phenotypes and has provided a context to interpret additional supporting evidence accumulating from parallel expression profiling studies in brains and peripheral blood of patients. Here we review relevant evidence that supports this connection and explore possible mechanisms that underlie the contribution of individual miRNAs and miRNA-related pathways to the pathogenesis and pathophysiology of these complex clinical phenotypes. The existing evidence provides useful hypotheses for further investigation as well as important clues for identifying novel therapeutic targets.

摘要

MicroRNAs (miRNA),一类非编码 RNA,正在成为神经元发育、结构和功能的重要调节因子。miRNA 表达异常与 miRNA 介导的基因调控以及精神和神经发育障碍以及认知功能障碍之间的联系已经建立起来。这种联系的确立是由阐明这些表型的遗传病因学的进展推动的,并为从患者大脑和外周血的平行表达谱研究中积累的额外支持证据提供了一个解释的背景。在这里,我们回顾了支持这种联系的相关证据,并探讨了个体 miRNA 和 miRNA 相关途径对这些复杂临床表型发病机制和病理生理学的贡献的可能机制。现有证据为进一步研究提供了有用的假设,也为识别新的治疗靶点提供了重要线索。

相似文献

1
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.神经精神疾病和认知功能障碍中的 microRNA 失调。
Neurobiol Dis. 2012 May;46(2):291-301. doi: 10.1016/j.nbd.2012.02.016. Epub 2012 Mar 3.
2
MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?微小 RNA 与神经认知功能障碍:药物治疗的新分子靶点?
Curr Neuropharmacol. 2017;15(2):260-275. doi: 10.2174/1570159x14666160709001441.
3
The Dysregulation of microRNAs and the Role of Stress in the Pathogenesis of Mental Disorders.microRNAs 的失调与应激在精神障碍发病机制中的作用。
Curr Top Med Chem. 2018;18(21):1893-1907. doi: 10.2174/1568026619666181130135253.
4
miRNA genes and the brain: implications for psychiatric disorders.miRNA 基因与大脑:对精神疾病的影响。
Hum Mutat. 2010 Nov;31(11):1195-204. doi: 10.1002/humu.21344. Epub 2010 Oct 14.
5
Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders.利用循环 microRNAs 作为精神障碍的生物标志物。
Mol Diagn Ther. 2020 Jun;24(3):279-298. doi: 10.1007/s40291-020-00464-9.
6
MicroRNAs in psychiatric and neurodevelopmental disorders.精神疾病和神经发育障碍中的 microRNAs。
Brain Res. 2010 Jun 18;1338:78-88. doi: 10.1016/j.brainres.2010.03.109. Epub 2010 Apr 10.
7
MicroRNAs and synaptic plasticity--a mutual relationship.微小RNA与突触可塑性——一种相互关系。
Philos Trans R Soc Lond B Biol Sci. 2014 Sep 26;369(1652). doi: 10.1098/rstb.2013.0515.
8
Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeutics
.基因组学与精神药理学的未来:微小RNA提供了新的治疗方法。
Dialogues Clin Neurosci. 2019;21(2):131-148. doi: 10.31887/DCNS.2019.21.2/dgurwitz.
9
Role of MicroRNA in Governing Synaptic Plasticity.微小RNA在调控突触可塑性中的作用。
Neural Plast. 2016;2016:4959523. doi: 10.1155/2016/4959523. Epub 2016 Mar 13.
10
MicroRNAs dysregulation in epilepsy.癫痫中微小RNA的失调
Brain Res. 2014 Oct 10;1584:94-104. doi: 10.1016/j.brainres.2013.09.049. Epub 2013 Oct 3.

引用本文的文献

1
Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort.血浆微小RNA作为约旦队列中精神分裂症的潜在生物标志物。
Noncoding RNA Res. 2024 Jan 30;9(2):350-358. doi: 10.1016/j.ncrna.2024.01.018. eCollection 2024 Jun.
2
Mapping miRNA Research in Schizophrenia: A Scientometric Review.精神分裂症 miRNA 研究的绘制:一项科学计量学综述。
Int J Mol Sci. 2022 Dec 27;24(1):436. doi: 10.3390/ijms24010436.
3
Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke.外泌体在缺血性脑卒中发病机制、诊断及治疗中的作用
Front Bioeng Biotechnol. 2022 Dec 16;10:980548. doi: 10.3389/fbioe.2022.980548. eCollection 2022.
4
miR-218: A Stress-Responsive Epigenetic Modifier.微小RNA-218:一种应激反应性表观遗传修饰因子。
Noncoding RNA. 2022 Jul 21;8(4):55. doi: 10.3390/ncrna8040055.
5
The Role of Epigenetic Modifications in Neurotoxicity Induced by Neonatal General Anesthesia.表观遗传修饰在新生儿全身麻醉诱导的神经毒性中的作用
Front Mol Neurosci. 2022 Apr 27;15:877263. doi: 10.3389/fnmol.2022.877263. eCollection 2022.
6
The Role of MicroRNA and Microbiota in Depression and Anxiety.微小RNA与微生物群在抑郁和焦虑中的作用
Front Behav Neurosci. 2022 Mar 1;16:828258. doi: 10.3389/fnbeh.2022.828258. eCollection 2022.
7
TSMDA: Target and symptom-based computational model for miRNA-disease-association prediction.TSMDA:用于miRNA-疾病关联预测的基于靶点和症状的计算模型
Mol Ther Nucleic Acids. 2021 Aug 26;26:536-546. doi: 10.1016/j.omtn.2021.08.016. eCollection 2021 Dec 3.
8
Enrichment and Correlation Analysis of Serum miRNAs in Comorbidity Between Arnold-Chiari and Tourette Syndrome Contribute to Clarify Their Molecular Bases.阿诺德-奇亚里畸形与图雷特综合征共病中血清微小RNA的富集及相关性分析有助于阐明其分子基础。
Front Mol Neurosci. 2021 Jan 5;13:608355. doi: 10.3389/fnmol.2020.608355. eCollection 2020.
9
Restraint Stress in Mice Alters Set of 25 miRNAs Which Regulate Stress- and Depression-Related mRNAs.小鼠的束缚应激改变了一组25个调控与应激和抑郁相关mRNA的miRNA。
Int J Mol Sci. 2020 Dec 12;21(24):9469. doi: 10.3390/ijms21249469.
10
Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.自闭症相关的 miR-873 调节 ARID1B、SHANK3 和 NRXN2,这些基因参与神经发育。
Transl Psychiatry. 2020 Dec 1;10(1):418. doi: 10.1038/s41398-020-01106-8.

本文引用的文献

1
Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets.精神分裂症相关基因CSMD1、C10orf26、CACNA1C和TCF4作为miR-137靶标的验证。
Mol Psychiatry. 2013 Jan;18(1):11-2. doi: 10.1038/mp.2011.170. Epub 2011 Dec 20.
2
The genetic architecture of schizophrenia: new mutations and emerging paradigms.精神分裂症的遗传结构:新的突变和新兴的范式。
Annu Rev Med. 2012;63:63-80. doi: 10.1146/annurev-med-072010-091100. Epub 2011 Oct 27.
3
Genome-wide association study identifies five new schizophrenia loci.全基因组关联研究确定了五个新的精神分裂症易感基因位点。
Nat Genet. 2011 Sep 18;43(10):969-76. doi: 10.1038/ng.940.
4
Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants.替代 miRNA 生物发生途径和核心 miRNA 途径突变体的解释。
Mol Cell. 2011 Sep 16;43(6):892-903. doi: 10.1016/j.molcel.2011.07.024.
5
MicroRNAs can generate thresholds in target gene expression.微小 RNA 可以在靶基因表达中产生阈值。
Nat Genet. 2011 Aug 21;43(9):854-9. doi: 10.1038/ng.905.
6
Exome sequencing supports a de novo mutational paradigm for schizophrenia.外显子组测序支持精神分裂症的新生突变模式。
Nat Genet. 2011 Aug 7;43(9):864-8. doi: 10.1038/ng.902.
7
A resource of vectors and ES cells for targeted deletion of microRNAs in mice.用于在小鼠中靶向敲除 microRNAs 的载体和 ES 细胞资源。
Nat Biotechnol. 2011 Aug 7;29(9):840-5. doi: 10.1038/nbt.1929.
8
Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.避免精神分裂症遗传学中的“陷阱”:当前和新兴的小鼠模型带来的经验和希望。
Neuroscience. 2012 Jun 1;211:136-64. doi: 10.1016/j.neuroscience.2011.07.051. Epub 2011 Jul 27.
9
Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells.14q32 印迹的 DLK1-DIO3 区域在外周血单个核细胞中定义了一个与精神分裂症相关的 miRNA 特征。
Mol Psychiatry. 2012 Jul;17(8):827-40. doi: 10.1038/mp.2011.78. Epub 2011 Jul 5.
10
Experimental strategies for microRNA target identification.miRNA 靶基因识别的实验策略
Nucleic Acids Res. 2011 Sep 1;39(16):6845-53. doi: 10.1093/nar/gkr330. Epub 2011 Jun 7.